235 related articles for article (PubMed ID: 31767751)
1. High-throughput assessment of hemoglobin polymer in single red blood cells from sickle cell patients under controlled oxygen tension.
Di Caprio G; Schonbrun E; Gonçalves BP; Valdez JM; Wood DK; Higgins JM
Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25236-25242. PubMed ID: 31767751
[TBL] [Abstract][Full Text] [Related]
2. Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease.
Schroeder P; Fulzele K; Forsyth S; Ribadeneira MD; Guichard S; Wilker E; Marshall CG; Drake A; Fessler R; Konstantinidis DG; Seu KG; Kalfa TA
J Pharmacol Exp Ther; 2022 Mar; 380(3):210-219. PubMed ID: 35031585
[TBL] [Abstract][Full Text] [Related]
3. A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells.
Nakagawa A; Ferrari M; Schleifer G; Cooper MK; Liu C; Yu B; Berra L; Klings ES; Safo RS; Chen Q; Musayev FN; Safo MK; Abdulmalik O; Bloch DB; Zapol WM
Mol Pharm; 2018 May; 15(5):1954-1963. PubMed ID: 29634905
[TBL] [Abstract][Full Text] [Related]
4. Identification of a small molecule that increases hemoglobin oxygen affinity and reduces SS erythrocyte sickling.
Nakagawa A; Lui FE; Wassaf D; Yefidoff-Freedman R; Casalena D; Palmer MA; Meadows J; Mozzarelli A; Ronda L; Abdulmalik O; Bloch KD; Safo MK; Zapol WM
ACS Chem Biol; 2014 Oct; 9(10):2318-25. PubMed ID: 25061917
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Evaluation of Allosteric Effectors for Hemoglobin.
Enakaya NA; Jefferson A; Chew-Martinez D; Matthews JS
Acc Chem Res; 2023 Jun; 56(11):1279-1286. PubMed ID: 36946781
[TBL] [Abstract][Full Text] [Related]
6. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
Noguchi CT; Rodgers GP; Schechter AN
Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
[TBL] [Abstract][Full Text] [Related]
7. Sickle Cell Hemoglobin.
Mandal AK; Mitra A; Das R
Subcell Biochem; 2020; 94():297-322. PubMed ID: 32189305
[TBL] [Abstract][Full Text] [Related]
8. Increased hemoglobin affinity for oxygen with GBT1118 improves hypoxia tolerance in sickle cell mice.
Dufu K; Williams AT; Muller CR; Walser CM; Lucas A; Eaker AM; Alt C; Cathers BE; Oksenberg D; Cabrales P
Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H400-H411. PubMed ID: 34213392
[TBL] [Abstract][Full Text] [Related]
9. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
[TBL] [Abstract][Full Text] [Related]
10. Allosteric control of hemoglobin S fiber formation by oxygen and its relation to the pathophysiology of sickle cell disease.
Henry ER; Cellmer T; Dunkelberger EB; Metaferia B; Hofrichter J; Li Q; Ostrowski D; Ghirlando R; Louis JM; Moutereau S; Galactéros F; Thein SL; Bartolucci P; Eaton WA
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15018-15027. PubMed ID: 32527859
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence Lifetime Measurement of Prefibrillar Sickle Hemoglobin Oligomers as a Platform for Drug Discovery in Sickle Cell Disease.
Vunnam N; Hansen S; Williams DC; Been MO; Lo CH; Pandey AK; Paulson CN; Rohde JA; Thomas DD; Sachs JN; Wood DK
Biomacromolecules; 2022 Sep; 23(9):3822-3830. PubMed ID: 35944154
[TBL] [Abstract][Full Text] [Related]
12. Polymerization in erythrocytes containing S and non-S hemoglobins.
Noguchi CT
Biophys J; 1984 Jun; 45(6):1153-8. PubMed ID: 6743746
[TBL] [Abstract][Full Text] [Related]
13. Effect of hemoglobin concentration on nucleation and polymer formation in sickle red blood cells.
Corbett JD; Mickols WE; Maestre MF
J Biol Chem; 1995 Feb; 270(6):2708-15. PubMed ID: 7852341
[TBL] [Abstract][Full Text] [Related]
14. Polymerization of hemoglobin in sickle trait erythrocytes and lysates.
Noguchi CT; Torchia DA; Schechter AN
J Biol Chem; 1981 May; 256(9):4168-71. PubMed ID: 7217076
[TBL] [Abstract][Full Text] [Related]
15. New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?
Oder E; Safo MK; Abdulmalik O; Kato GJ
Br J Haematol; 2016 Oct; 175(1):24-30. PubMed ID: 27605087
[TBL] [Abstract][Full Text] [Related]
16. Interactions of an Anti-Sickling Drug with Hemoglobin in Red Blood Cells from a Patient with Sickle Cell Anemia.
Strader MB; Liang H; Meng F; Harper J; Ostrowski DA; Henry ER; Shet AS; Eaton WA; Thein SL; Alayash AI
Bioconjug Chem; 2019 Mar; 30(3):568-571. PubMed ID: 30794381
[TBL] [Abstract][Full Text] [Related]
17. MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease.
Demers M; Sturtevant S; Guertin KR; Gupta D; Desai K; Vieira BF; Li W; Hicks A; Ismail A; Gonçalves BP; Di Caprio G; Schonbrun E; Hansen S; Musayev FN; Safo MK; Wood DK; Higgins JM; Light DR
Blood Adv; 2021 Mar; 5(5):1388-1402. PubMed ID: 33661300
[TBL] [Abstract][Full Text] [Related]
18. Hybrid erythrocytes for membrane studies in sickle cell disease.
Clark MR; Shohet SB
Blood; 1976 Jan; 47(1):121-31. PubMed ID: 1244907
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin polymerization in sickle cells studied by circular polarized light scattering.
Gross CT; Salamon H; Hunt AJ; Macey RI; Orme F; Quintanilha AT
Biochim Biophys Acta; 1991 Aug; 1079(2):152-60. PubMed ID: 1911838
[TBL] [Abstract][Full Text] [Related]
20. Effect of polymerization tendency on haematological, rheological and clinical parameters in sickle cell anaemia.
Keidan AJ; Sowter MC; Johnson CS; Noguchi CT; Girling AJ; Stevens SM; Stuart J
Br J Haematol; 1989 Apr; 71(4):551-7. PubMed ID: 2469459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
